This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Sep;23(9):1099-1100.

doi: 10.1002/lt.24822.

Direct-acting antivirals and recurrence of hepatocellular carcinoma

Jorge A Marrero¹, Amit G Singal¹

Affiliations

PMID: 28722785
DOI: 10.1002/lt.24822

Editorial

Direct-acting antivirals and recurrence of hepatocellular carcinoma

Jorge A Marrero et al. Liver Transpl. 2017 Sep.

. 2017 Sep;23(9):1099-1100.

doi: 10.1002/lt.24822.

Authors

Jorge A Marrero¹, Amit G Singal¹

Affiliation

¹ Division of Digestive and Liver, Disease UT Southwestern Medical Center, Dallas, TX.

PMID: 28722785
DOI: 10.1002/lt.24822

No abstract available

PubMed Disclaimer

Comment on

Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
Zanetto A, Shalaby S, Vitale A, Mescoli C, Ferrarese A, Gambato M, Franceschet E, Germani G, Senzolo M, Romano A, Angeli P, Rugge M, Farinati F, Forton DM, Cillo U, Burra P, Russo FP. Zanetto A, et al. Liver Transpl. 2017 Sep;23(9):1103-1112. doi: 10.1002/lt.24790. Liver Transpl. 2017. PMID: 28544587

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information